RVX-208: Additional Phase Ib/IIa data

Additional data from a double-blind, Phase Ib/IIa trial in 72 subjects, about half of whom had low levels of baseline HDL cholesterol, showed that 1mg/kg RVX-208 twice daily led to plasma APOA1 increa...